Home/Enara Bio/Kevin Pojasek
KP

Kevin Pojasek

President and CEO

Enara Bio

Therapeutic Areas

Enara Bio Pipeline

DrugIndicationPhase
ENA101 (targeting DARKFOX)Solid TumorsPre-clinical